Literature DB >> 29554402

Quality of life in patients with larynx cancer in Latin America: Comparison between laryngectomy and organ preservation protocols.

Alvaro Sanabria1, Daniel Sánchez, Andrés Chala, Andres Alvarez.   

Abstract

The effect on quality of life (QOL) of laryngectomy and organ preservation protocols is important in decision making. The aim of this cross-sectional study was to evaluate QOL outcomes of patients with advanced laryngeal tumors who were treated with laryngectomy or organ preservation protocols in Latin America. A total of 35 patients from three oncology units were enrolled. Patients with stage III/IV laryngeal cancer who were treated using organ preservation protocols or laryngectomy were assessed with the University of Washington QOL Questionnaire. The most important domains that affected QOL for both groups were speech and activity. In the laryngectomy group, the next most important domains were appearance, taste, pain, and recreation, whereas in the organ preservation group, they were saliva, recreation, mood, and swallowing. There were no statistically or clinically significant differences in the global score or the 7 days of QOL assessments before patients were interviewed. Global QOL assessments were similar when comparing laryngectomy and organ preservation protocols.

Entities:  

Mesh:

Year:  2018        PMID: 29554402     DOI: 10.1177/014556131809700323

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  2 in total

Review 1.  Current Role of Total Laryngectomy in the Era of Organ Preservation.

Authors:  Alexandre Bozec; Dorian Culié; Gilles Poissonnet; Olivier Dassonville
Journal:  Cancers (Basel)       Date:  2020-03-03       Impact factor: 6.639

2.  Quality of life among total laryngectomized patients undergoing speech rehabilitation: correlation between several instruments.

Authors:  Ana Carolina Soares Raquel; Elaine Pires Buzaneli; Hevely Saray Lima Silveira; Marcia Simões-Zenari; Marco Aurélio Valmondes Kulcsar; Luiz Paulo Kowalski; Kátia Nemr
Journal:  Clinics (Sao Paulo)       Date:  2020-11-11       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.